Hani Najm, MD, MSc, FACC, Chair of Pediatric and Congenital Heart Surgery, has been elected to the board of trustees of the American College of Cardiology (ACC).
Visit with Our Experts at ACC.18 Booth 1700
If you’re at ACC.18, stop by Cleveland Clinic’s booth (1700) to chat with our specialist physicians. Here’s a rundown of who’ll be there and when.
New Hypertension Guidelines: How to Approach Your Patients
Instead of one in three U.S. adults having hypertension, nearly one in two will now be classified as having hypertension. Accurate measurements in and out of the office are key. Lifestyle changes are getting major emphasis.
Valve-in-Valve TAVR’s Safety Is Validated in Major Registry Study
The lead investigator of the STS/ACC TVT Registry study presented at ACC.17 explains why its findings suggest valve-in-valve TAVR might be the treatment of choice for inoperable and even high-risk patients.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Dr. Nissen Recaps PCSK9 News from ACC (Video)
FOURIER was the big news out of ACC, but other PCSK9 inhibitor trials mattered as well, including its EBBINGHAUS substudy and the SPIRE and ORION-1 trials. Dr. Steven Nissen outlines the takeaways.
New PARTNER 2A Insights: Worsened RV Function and Tricuspid Regurgitation More Common with SAVR Vs. TAVR
The transcatheter approach to aortic valve replacement in intermediate-risk patients appears to curb the risk of these potentially deadly effects, new subanalyses presented at ACC.17 show.
ABSORB III at Two Years: Jury’s Still Out on Bioresorbable Stent Vs. DES
Lead investigator of the pivotal study of the new bioresorbable stent explains the nuanced interim results (straight from ACC.17) and what to expect next.
Get These Presentations into Your ACC.17 Itinerary
Make room in your schedule at the American College of Cardiology meeting for key presentations ranging from the SPIRE 1 and 2 trials to ABSORB III two-year results and more.
Going to ACC.17? This Symposium Puts Leading-Edge Practice into Context
This free Thursday dinner symposium at ACC.17 can help attendees make the most of the many advancements discussed at the larger meeting. The course directors explain why you shouldn’t miss it.
Heart Failure Studies at ACC: The Good, the Bad and the Nuances (Video)
Two big studies of interest to heart failure specialists were presented at the American College of Cardiology meeting this spring. While STICH was considered positive and INOVATE-HF a disappointment, there’s much more to be gleaned from the nuances of each.